Location History:
- London, DE (1998)
- London, GB (2000 - 2006)
Company Filing History:
1 out of 1 
1 out of 3 
1 out of 176 
Years Active: 1998-2006
Title: Fariba Shojaee-Moradi: Innovator in Hepatoselective Pharmaceutical Actives
Introduction
Fariba Shojaee-Moradi is a distinguished inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of hepatoselective pharmaceutical actives. With a total of 4 patents to her name, her work has the potential to impact insulin replacement therapy and other medical applications.
Latest Patents
Fariba's latest patents include innovative formulations that enhance the efficacy of pharmaceutical actives. One of her notable inventions is an analogue of a pharmaceutical active with a molecular weight of less than 25,000 Daltons. This analogue is covalently linked to a pendant molecular group, resulting in an active complex with a molecular weight of 25,000 Daltons or greater in the circulatory system. This hepatoselective analogue is particularly significant for insulin therapy, as it may improve the delivery and effectiveness of insulin in patients.
Another patent focuses on pharmaceutical active conjugates, which share similar characteristics to her previous invention. These conjugates also aim to enhance the delivery of insulin and other pharmaceutical actives, making them more effective in treating various conditions.
Career Highlights
Throughout her career, Fariba has worked with reputable organizations, including the Deutsches Wollforschungsinstitut. Her experience in these institutions has allowed her to collaborate with leading experts in the field, further advancing her research and innovations.
Collaborations
Fariba has collaborated with notable professionals such as Peter Henri Sonksen and Dietrich Brandenburg. These partnerships have contributed to her success and the development of her groundbreaking patents.
Conclusion
Fariba Shojaee-Moradi is a pioneering inventor whose work in hepatoselective pharmaceutical actives is paving the way for advancements in medical therapies. Her contributions to the field are invaluable and continue to inspire future innovations.